Form 4: Vivani Medical Director Daniel Bradbury Acquires Stock Options in Lieu of Cash Retainer
SEC Form 4 Filing
Director Daniel Bradbury acquired 26,145 non-qualified stock options in Vivani Medical, Inc. in lieu of $37,500 in cash retainer fees.
Summary
- On March 27, 2024, Daniel Bradbury, a director of Vivani Medical, Inc., acquired 26,145 non-qualified stock options.
- The options were awarded in lieu of pro-rated cash retainer fees of $37,500, pursuant to the Issuer's non-employee director compensation policy.
- The exercise price of the options is $1.85.
- The options vest quarterly through December 31, 2024, and expire on March 26, 2034.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. It reflects a standard compensation practice, with a director choosing equity over cash, which can be interpreted as a sign of confidence.
Positives
- The acquisition of stock options by a director aligns their interests with those of the shareholders.
- The director chose to receive stock options instead of cash, which could be seen as a positive signal about their confidence in the company's future.
Industry Context
This is a standard practice for compensating non-employee directors, aligning their interests with the long-term success of the company. Many companies offer stock options as part of their compensation packages to directors.
Comparison to Industry Standards
- Granting stock options to directors is a common practice among publicly traded companies, particularly in the biotech and pharmaceutical industries.
- The vesting schedule and exercise price appear to be within typical ranges for director compensation packages.
- Comparing Vivani Medical's director compensation package to those of similar-sized companies in the same industry would provide a more detailed benchmark.
Stakeholder Impact
- Shareholders may view the director's acceptance of stock options as a positive sign, aligning their interests with the company's long-term performance.
- The company conserves cash by issuing stock options instead of paying cash retainer fees.
Key Dates
| Date | Description |
|---|---|
| 03/27/2024 | Date of transaction: Daniel Bradbury acquired stock options. |
| 12/31/2024 | End of vesting period for the stock options. |
| 03/26/2034 | Expiration date of the stock options. |
| 03/29/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.